Samulski, Richard J
- University of North Carolina at Chapel Hill · Microbiology & Immunology (NIH department code)
From the FY2014 NIH awards this investigator leads as contact PI. The department is the award's.
FY2014 NIH rank #31,852
- Sustained Excellence
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2014Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2014 award categories
- Microbiology & Immunology
NIH Funding · FY2014
Linked Award Amount
$190K
Full award amounts, FY2014
Award Records
1
Records listing this PI
Award-Linked Rank
#31,852
By linked amount among FY2014 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2014 award records by amount
NIH award records listing Samulski, Richard J as a PI. Multi-PI records show the full award amount for context.
- 5R21AI104431-02R21Contact PIDevelopment of Human beta cell-specific AAV Vectors for Type I DiabetesUniversity of North Carolina at Chapel Hill · Microbiology & Immunology (NIH department code)$190Kaward amount
Award organization
Organizations that administered FY2014 awards listing Samulski, Richard J as a PI.
FY2014 award administered by University of North Carolina at Chapel Hill (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardUniversity of North Carolina at Chapel Hill
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001$2M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #960
- 2001Entered Top 25% NationallyRanked #960
- 2001Entered Top 10% NationallyRanked #960
- 2001Entered Top 5% NationallyRanked #960
- 2003$5M Cumulative Funding
- 2005$10M Cumulative Funding